Compare PCVX & KRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCVX | KRG |
|---|---|---|
| Founded | 2013 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 5.2B |
| IPO Year | 2020 | 2004 |
| Metric | PCVX | KRG |
|---|---|---|
| Price | $54.00 | $25.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 10 |
| Target Price | ★ $98.33 | $25.60 |
| AVG Volume (30 Days) | 1.0M | ★ 1.8M |
| Earning Date | 01-01-0001 | 05-20-2026 |
| Dividend Yield | N/A | ★ 4.58% |
| EPS Growth | N/A | ★ 6750.00 |
| EPS | N/A | ★ 1.37 |
| Revenue | N/A | ★ $844,365,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.27 |
| P/E Ratio | ★ N/A | $18.51 |
| Revenue Growth | N/A | ★ 0.30 |
| 52 Week Low | $28.09 | $18.52 |
| 52 Week High | $76.61 | $26.38 |
| Indicator | PCVX | KRG |
|---|---|---|
| Relative Strength Index (RSI) | 40.33 | 44.14 |
| Support Level | $42.30 | $21.95 |
| Resistance Level | $57.50 | $26.38 |
| Average True Range (ATR) | 3.05 | 0.45 |
| MACD | -0.94 | -0.17 |
| Stochastic Oscillator | 1.39 | 18.93 |
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
Kite Realty Group Trust specializes in owning, operating, acquiring, developing, and redeveloping high-quality open-air shopping centers and mixed-use assets. The company generates the majority of its revenue from contractual rents and reimbursement payments received from tenants.